Lief
A chest-worn ECG patch that buzzes you into slow breathing. The method has decent evidence; Lief's best trial is in addiction recovery, and there are no returns.
A chest-worn ECG patch that buzzes you into slow breathing. The method has decent evidence; Lief's best trial is in addiction recovery, and there are no returns.
You're in the car after a meeting that went sideways, and only when you reach for the door handle do you notice your clenched jaw and shallow breathing. By the time most of us notice stress, it's been running the show for an hour.
That's the gap Lief aims at. It watches your heart rhythm and taps you on the ribs when things tighten. Clever idea. The question is whether the patch, the price and the fine print earn it.
Lief is made by Lief Therapeutics, a small San Francisco company led by founder and CEO Rohan Dixit.
It goes at the top of your left rib cage, just below the breast, on clean, dry, lotion-free skin. Each sticker pair lasts two to five days.
Lief's help pages admit stickers can cause redness or itching. The patch is "sweat-proof," but heavy sweat loosens the stickers, and Lief suggests not wearing it while sweating. If hot flashes run your afternoons, that's a real problem. An athletic strap ($49.99) skips the stickers, but it's a chest strap all day.
Lief says nothing about bras, and we found no owner reports. It sits roughly where a bra band does, so that's a try-it question, with no returns.
No. Lief's help center calls it "an FDA class II medical device," and the FDA's database lists a "Lief Rx" as a Class II biofeedback device. But that category is exempt from FDA review when prescribed for relaxation training, and we found no FDA clearance.
Partly. Your heart slows slightly each time you breathe out, and that slowing is your vagus nerve at work. Lief's buzz lands on that moment. But the vibration is a cue, not a stimulus; your breath does the work. More in the Trackers.
The method: decent. A 2017 meta-analysis of 24 studies with 484 people linked HRV biofeedback to a large drop in self-reported stress and anxiety, though the authors wanted better-controlled trials. That's evidence for the technique, not for Lief.
Lief's anxiety pilot (2021): tiny. Fourteen people finished eight weeks with the patch and four coaching calls, and scores on a two-question anxiety screener fell from 4.6 to 1.7 out of 6. No comparison group, Lief paid for it, and the lead author owned equity in Lief. Participants were 24 to 47.
The real trial (2025): good, but about something else. In JAMA Psychiatry, a team led from Massachusetts General Hospital and Harvard Medical School randomly assigned 115 adults in early recovery from substance use to Lief plus usual treatment, or usual treatment alone. US government grants paid for it. Over eight weeks, negative mood and craving fell with Lief and rose without it, and the Lief group had 64% fewer days of drinking or drug use. The caveats: no sham device, no follow-up, and only about a quarter hit half their practice target. The average participant was 46; 60% were women.
So, "clinically validated"? For early addiction recovery, one encouraging trial. For everyday anxiety, one uncontrolled pilot. For sleep, nothing Lief-specific we could find. The Science explains why that gap matters.
And "Harvard and Stanford collaborators"? The Harvard link is that independent, government-funded trial. Lief's founder describes himself as a former Stanford and Harvard researcher, and Lief says its coaches are "Stanford-trained." We found no formal partnership with either university.
As of October 2026, the iPhone app shows 4.0 stars from just 2 ratings, and search listings put Google Play at about three stars from a few dozen reviews. There are no Trustpilot reviews, and independent hands-on reviews are scarce and old.
In older App Store reviews, fans say live HRV showed them when stress hit and the buzz taught them to catch it. Complaints cluster around the app: crashes after updates, Bluetooth dropouts, slow support, and one 2024 reviewer who couldn't find a working cancel button. Two reviewers boil it down to good hardware, frustrating app.
Prices as of October 2026.
Lief's trick is timing your out-breath to your heart's natural slowing. You can approximate it for free.
Breathe in through your nose for about four seconds, then out through pursed lips for about six, as if through a straw. Keep going for five minutes. Then, for a week, set three daytime phone reminders for a three-minute version: a homemade autodose.
If the reminders work, you've saved $399. If you ignore them, the buzz on your ribs is what you'd be paying for. More free options are in the Analogs.
The technique has reasonable evidence for stress and anxiety. The patch's best trial is in addiction recovery. For everyday stress and sleep, Lief-specific proof is thin.
Possibly, if you want all-day nudges and don't mind stickers. With no returns, I'd try free paced breathing first.
On your chest just under the left breast, with two sticky ECG pads, or on a chest strap.
Different jobs. Lief measures your heart and cues you to breathe; Apollo vibrates to soothe you without measuring anything.
Lief puts a well-supported idea, slow breathing timed to your heart, on your ribs where it can catch stress as it happens. The sensor is the right kind, and the one serious trial is encouraging. But "clinically validated" stretches a tiny pilot and an addiction study, "Harvard and Stanford" is looser than it sounds, and a sticky patch is hard to love if you sweat. With no returns, I'd be sure before spending $399.
Start with five minutes of slow breathing tonight. If you keep forgetting, that's when the buzz starts to make sense.
An ear clip that shows your heart rhythm live as you breathe slowly. The method has real evidence; "heart-brain sync" is mostly slow breathing with good branding.
A headband that listens to your brain while you meditate and answers in sound. Its sleep tracking tested well in a lab; the case that brain feedback beats plain meditation is thin.
A daily check-in, fingertip HRV scan and short movement exercises. The camera reading holds up at rest; "relief in 7 days" rests on the company's own uncontrolled data.